CD33 and acute myeloid leukemia: In closing, she addressed the application of CAR-CIK cells to combat acute myeloid leukemia (AML) and explained how her team is currently working to characterize a trans-signaling dual CAR designed specifically for CD123 and CD33 target antigens.